Patents and Progress

Patent filings are at an all-time high, reports BusinessNewsDaily. In 2011, the most recent year for which there is data, about 250,000 patents were granted by the US Patent and Trademark Office, Business News Daily adds, drawing on a Brookings Institute study.

Most of the patents awarded domestically went to people living in about 20 metro areas, it says, especially regions with well-regarded graduate programs in the sciences. "The inventive capacity of regions is noticeably strengthened through educational attainment in STEM fields, academic training and research, collaboration, and public sector investments in basic and applied R&D," the report says.

Since innovation appears to be clustered in certain areas, the Brookings report also suggests that law- and policy-makers at different levels of government "consider ways to foster these attributes more broadly and generally support research and development."

This Week in PNAS

Soil and manure from pig farms where antibiotics are commonly used are prone to harboring antibiotic resistance genes, according to a study in the early, online edition of the Proceedings of the National Academy of Sciences. Researchers from China and the US assessed manure, manure compost, and manure compost-treated soil samples from three large Chinese swine farms, using quantitative PCR arrays to test for 244 antibiotic resistance genes. The search uncovered signs of 149 different antibiotic resistance genes, the group reports, with sequences from a subset of these genes being especially enriched at the commercial swine farm site samples compared to control manure and soil samples Based on the patterns they saw, Michigan State University microbial ecology researcher James Tiedje, the study's senior author, and colleagues concluded that "diverse, abundant, and potentially mobile [antibiotic resistance genes] in farm samples suggest that unmonitored use of antibiotics and metals is causing the emergence and release of [antibiotic resistance genes] to the environment."

In another PNAS study, the University of Oxford's Zoltán Molnár and colleagues from the UK explore gene expression during brain development in mice, focusing on part of the cerebral cortex called the subplate zone. Using array- and RNA sequencing-based data from brain samples collected during mouse embryonic development and in post-natal and adult mice, the researchers gained clues about subplate function by finding genes with distinct expression profiles in that brain area during at least one of the developmental stages considered. Moreover, the group also saw enhanced mouse subplate expression for several of the same genes implicated in past studies of autism and schizophrenia, prompting them to argue for "the importance of the study of transient features of the developing brain to better understand neurodevelopmental disorders."

A team from the UK and the US performed genome-wide copy number analyses on multiple samples from within individual tumors taken from 11 individuals with glioblastoma. Based on alterations across different parts of each tumor, the investigators put together tumor-specific phylogenies and tracked genetic glitches signifying cancer progression in each patient. "Our results reveal the genome-wide architecture of intra-tumor variability in [glioblastoma] across multiple spatial scales and patient-specific patterns of cancer evolution, with consequences for treatment design," the study's authors wrote in a paper slated to appear online this week in PNAS.

A Cut for the EU Budget

The effect of the European Union budget talks "is decidedly mixed for scientists," ScienceInsider reports. At the talks, EU leaders decided on a 3.4 percent cut to the EU budget, which comes to a €960 billion budget for 2014 to 2020.

However, one aspect of the budget that includes research funding would get a substantial — 37 percent — boost, ScienceInsider adds, though it notes that that is less than what researchers had been lobbying for. Further, the Horizon 2020 science program is to receive €70.96 billion, less than the proposed €80 billion, but more than what the current science funding has received.

"Our feeling is that €80 billion is required to deliver on the ambitious and exciting proposal that the commission presented," Paul Boyle, the president of Science Europe and the chief executive of the UK's Economic and Social Research Council, says. "Anything other than that is disappointing news from Science Europe's perspective."

The budget, ScienceInsider adds, is not final as it awaits approval by the European Parliament.

Supreme Court Hearing on Crime Suspects' DNA Looms

On Wired's Threat Level blog, David Kravets describes an upcoming US Supreme Court case that is expected to address whether authorities can take DNA samples from anybody arrested for a serious crime.

According to Kravets, "at least 27 states and the federal government have regulations requiring suspects to give a DNA sample upon some type of arrest, regardless of conviction."

"The upcoming hearing, slated for Feb. 26, has drawn a huge following from civil rights groups, crime victims, federal and state prosecutors and police associations — each arguing their party lines," he writes.

The Supreme Court will be charged with upholding or rejecting a previous decision by the Maryland Court of Appeals in a case involving a man, Alonzo King, who was arrested in 2009 on assault charges, and then convicted for a rape committed years earlier based on a DNA match.

The Maryland court overturned King's conviction, concluding that arrestees do have a Fourth Amendment-guaranteed "weighty and reasonable expectation of privacy against warrantless, suspicionless searches," which is not outweighed by the state's need to accurately identify a suspect via DNA.

According to Kravets, the Supreme Court is probably going to reverse the lower court's conclusion, having suggested as much when it stayed the Maryland decision last July.

Virome Mystery

Not only is the human body covered inside and out with bacteria, it is also home to a large number of viruses. "But, truth be told, a lot of viruses we harbor don't make us sick. They may even make us healthy. You'd think they'd be worth getting to know. But they're mostly a mystery to us," writes Carl Zimmer at The Loom. He notes, though, that researchers are beginning to try to solve that mystery.

Forest Rohwer from San Diego State University is starting to get a glimpse of the human virome, writes Sarah Williams in a news piece in the Proceedings of the National Academy of Sciences. Rohwer has, she writes, examined the virome of cystic fibrosis patients' lungs, and he says that the viruses present there could influence disease severity.

Study the virome, though, poses a technical issue, Williams adds. To study the bacterial component of the microbiome, researchers often turn to 16S rRNA, but viruses don't have that or even something equivalent to that, she writes. Instead, researchers are using shotgun sequencing or a viral purification approach followed by sequencing.

"We don't know how much we're missing right now," Rohwer tells her, "but we know that every time we change techniques, we find new viruses."

The Emotion of it All

Science, Ewan Birney writes in The Observer, can be much more emotional than journal papers can lead people to believe. He recalls a heated argument with a colleague over a set of experiments. "We must have been a sight: two geeks wildly gesticulating and laughing, happy to be friends after a virtual plate-throwing fight," Birney writes, adding "this is not what you write up in your scientific paper."

Other emotions — happiness as well as frustration — come out, too, Birney writes. "Pivotal moments in science can cause an outright physical reaction – a wave of giddiness when you realise you've backed the right idea," he says, but then there also is "the sinking feeling when you just can't make an idea fit."

This Week in PLOS

In PLOS One, researchers from the University of Massachusetts at Amherst and the University of Pennsylvania report on an analytical technique known as "mixed modeling of meta-analysis p-values," or MixMAP. The statistical method is designed to unearth associations at the locus level from existing data from genome-wide association studies, they say, by taking into account both SNP-level associations and genome structure. In the new study, for instance, the team tracked down 12 new gene-level loci suspected of influencing low density cholesterol data using information from a Global Lipids Gene Consortium GWAS, along with additional gene candidates ascertained using data from a smaller association study. See more on this study from our sister publication GenomeWeb Daily News.

Hantavirus may have appeared in bats or insectivorous animals before moving to rodent hosts, according to a new PLOS Pathogens study. A group of researchers based in China, Australia, and the US screened for hantavirus in hundreds of Chinese bats from several species as well as several dozen shrews from two species. That search uncovered four new hantaviruses, researchers report, while phylogenetic analyses of new and previously known hantaviruses pointed to the existence of at least four different hantavirus phylogroups infecting mammals. From relationships between the viruses, study authors also determined that "hantaviruses might have first appeared in Chiroptera (bats) or Soricomorpha (moles and shrews), before emerging in rodent species." "Our study shows that bats are likely to be important natural reservoir hosts of hantaviruses," they add, "from which novel hantaviruses may emerge in the future."

The Max Planck Institute for Molecular Genetics' Markus Morkel and colleagues from Germany describe regions of the mouse genome that become differentially methylated during colon cancer development. These loci are conserved to some extent in human forms of colon cancer, the investigators say in PLOS Genetics. They used methylated DNA immunoprecipitation coupled with high-throughput sequencing — or MeDIP-Seq — to test intestinal samples from mouse models of colon cancer, focusing first on benign adenoma precursors to disease. The team tracked down more than 13,000 sites in the genome with differential methylation in adenomas compared to normal controls. Follow-up experiments indicated that many of the same sites are also differentially methylated in human colon cancer. "Our data allow a distinction between early conserved epigenetic alterations occurring in intestinal adenoma and late stochastic events promoting colon cancer progression," the study's authors write, "and may facilitate the selection of more specific clinical epigenetic biomarkers."

BGI Life

BGI, Bloomberg Businessweek's Lauren Hilgers writes, has established itself as the largest commercial genomic sequencing company in the world, powered by an army of young, college-educated workers — the average age of BGI's 3,000 workers is 26, she notes.

Not only is BGI expanding in China — when it was associated with the Chinese Academy of Sciences, it was limited to having 90 scientists — it is in the midst of acquiring California-based Complete Genomics, which, Hilgers says, will help BGI improve its data storage capabilities. "Even as BGI improves its technology, its biggest strength remains all those cheap, highly educated analysts," Hilgers adds.

Some workers live in BGI dorms and the company has a number of clubs as well as an annual basketball tournament; Jun Wang, the executive director of BGI likens it to a college campus, Hilgers says. Though, it's a college campus tackling a number of genomic projects.

"When I ask Wang how BGI determines which plants and animals to sequence as part of its '1,000 Plants and Animals' project, he answers, 'We start with anything tasty,'" Hilgers writes.

Science Minister Loses PhD

Annette Schavan, the German minister for education and research, has had her PhD invalidated among allegations of plagiarism, ScienceInsider reports. Schavan's lawyer says that she will be challenging the ruling in court.

Plagiarism concerns first came to light last May when a blogger noted that parts of Schavan's thesis were worded similarly to some of her sources, which were then not properly cited, an earlier ScienceInsider report noted. Then, an investigation, which was leaked in the fall, found that about 60 pages of the 351-page dissertation had such passages, the blog notes.

Schavan "systematically and deliberately claimed as her own intellectual achievements which she had in fact not produced herself," says Bruno Bleckmann, who headed the committee at the University of Dusseldorf that investigated the allegations, in a statement according to the Nature News blog.

The Nature News blog notes that this move will likely have political ramifications as Schavan is the second member of the German cabinet to have a PhD revoked for plagiarism.

This Week in Science

In Science this week, investigators from Oak Ridge National Laboratory report on the genetic basis for mercury methylation, the process of converting mercury into the neurotoxin methylmercury, by bacteria. The team examined the genomes of two sulfur-reducing bacteria — Desulfovibrio desulfuricans ND132 and Geobacter sulfurreducens PCA — and found that two genes, if deleted alone or together, abolishes the organisms' ability to process mercury. Because these genes are present in other lineages of bacteria and archaea, the ability to produce methylmercury may be more widespread than previously believed.

Also in Science, a multi-institute team of French researchers publish the crystal structure of papillomavirus proteins, offering a potential new target for fighting the infection, which is known to cause a variety of cancers including cervical cancer. Papillomaviruses rely on a protein called E6 to bind to and deactivate certain host proteins. The scientists determined the structure of both human and bovine E6 proteins bound to their host proteins and described two zinc domains and a linker helix that form a hydrophobic binding site. Mutational inactivation of this site disrupts the oncogenic activities of the E6 proteins, suggesting a new area for therapeutic intervention.

A Bioinformatician's Guide to Making Small Talk

This one's for bioinformaticians everywhere who've ever tried to explain their day jobs to people in social settings and watched as their listeners' eyes glazed over.

In a recent Genome Biology article, Alicia Oshlack, a senior research officer at the Walter and Eliza Hall Institute of Medical Research shares her creative 10-step plan to making sure that your audience understands the basics of your job without boring them silly.

Before launching into a monologue about your favorite sequence assembler and the difference between de novo and reference-based assembly, gauge whether your audience really wants to know what you do by providing general details about your field, Oshlack says. If their attention starts wandering mid-sentence or you see them eyeing the bar desperately, don't force the issue, start talking about something else — sports, politics, the weather, whatever.

Also, she says, try to give your listener an idea about just how big the human genome really is. Oshlack says she uses Tolstoy's War and Peace as an analogy. It has around three million letters in it, so the human genome would have as many letters as 1,000 copies of Tolstoy's book and a genetic disease would be "like having a typo in one of those copies," she writes.

Only after a few more steps, as well as checking in on whether your audience's interest is waning, can you dive into bioinformatics and why you are absolutely essential to genomics, she says. While you are at it, be sure to throw in some examples of thrilling discoveries that you've either been involved in or that you've read about, she says.

By following her plan, Oshlack says that you can ensure that at the end of a night out with friends or family party, at least a few people in the room won't be giving you a wide berth.

Multiple Tragedies

Amy Bishop, the University of Alabama in Huntsville biologist who pleaded guilty in the fall to the shooting deaths of three of her colleagues and the attempted murder of three others, had a tragic past, writes Patrick Radden Keefe at The New Yorker. He delves into not only the Alabama shootings — which, at first, appeared to be tied to Bishop's failed bid for tenure — but also the death of her brother Seth Bishop about 25 years earlier in Massachusetts.

Though Amy's shooting of Seth had been ruled accidental at the time, she has since been indicted in that case, though Keefe notes that the case is unlikely to go to trial. Keefe examines that case as there are a number of theories about what may have occurred or about how the case was handled by police or even by the town. In particular, he wonders whether if that case had been handled differently, if it could have made a difference down the line in Alabama.

"In the months that I spent talking with people in Braintree, I came to believe that there had indeed been a coverup, but that it had been an act not of conspiracy but of compassion," he writes, later adding that "it may have seemed that the most charitable way to address the confounding tragedy at Hollis Avenue was simply to move on — a parochial gesture of mercy and denial that had an incalculable cost, decades later, in Alabama."

Fun with DMCA

In a development sure to delight fans of research fraud everywhere, the Anil Potti saga has just taken a new twist.

John Timmer has a story in Ars Technica this week highlighting a DMCA takedown request aimed at Retraction Watch, which is written by Ivan Oransky and Adam Marcus. Essentially, an India-based website called NewsBulet.In apparently plagiarized 10 Retraction Watch stories, posting them on their site and claiming them as their own.

They then filed a DMCA takedown request alleging that Retraction Watch had plagiarized them, and demanded that WordPress, which hosts Retraction Watch, take the posts down, which it did.

Curiously enough, all 10 of the posts concerned Potti, the Duke cancer researcher who resigned in 2010 under accusations of lying on his resume and falsifying data.

Retraction Watch has since filed a challenge to the request and is waiting for it to be resolved. In the meantime, though, we can all enjoy speculating on who might be behind these DCMA shenanigans.

No one is pointing the finger at Potti, exactly, but Timmer does note that, in the past, the researcher hired a reputation management firm, "which dutifully went about creating websites with glowing things to say about [him]."

"The remarkable specificity of the request, with all the material focused on a single researcher, is worrisome," he adds.